News · 26 weeks32+300%
2026-03-012026-08-23
Mix2090d
- SEC Filings10(50%)
- Other9(45%)
- Earnings1(5%)
Latest news
25 items- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Announces Intention to Complete 30:1 Share Consolidation to Support Nasdaq Minimum Bid Price ComplianceTORONTO and GLIL YAM, Israel, Aug. 18, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, announces that the board of directors of the Company (the "Board") has approved a consolidation of its issued and outstanding common shares, no par value per share ("Common Shares") on the basis of one post-consolidated Common Share for every thirty pre-consolidated Common Shares (the "Consolidation"). The Board has authorized the Consolidation to be effected on or before September 15, 2026, with the Company currently expecting August 27, 2026 to
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Enters into Agreement to Sell IMC Holdings and European- Focused AssetsTransaction Expected to Result in an Improvement of Approximately CAD$3 million in Shareholders' EquityTORONTO and GLIL YAM, Israel, Aug. 17, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), today announced that, further to its press release dated June 18, 2026, it has entered into a definitive share purchase agreement dated August 16, 2026 (the "Share Purchase Agreement") with Slil.com Holding Ltd. ("Slil") and I.M.C. Holdings Ltd. ("IMC Holdings") pursuant to which the Company has agreed to sell to Slil all of the issued and outstanding shares of IMC Holdings (the "Transaction"). Prior to closing
- PRIM Cannabis Corp. Announces Second Quarter and First Half 2026 Financial ResultsTORONTO and GLIL YAM, Israel, Aug. 13, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), today announced its financial results for the three and six months ended June 30, 2026. All amounts are reported in Canadian dollars, unless otherwise stated.Financial Summary for the Six Months Ended June 30, 2026Revenue of $16.3 million, compared to $25.2 million in the same period in 2025.Gross profit of $2.9 million, compared to $6.9 million in the same period in 2025.Operating loss of $3.8 million, compared to $0.2 million in the same period in 2025.Net loss of $6.9 million, or $0.85 per share (basic and di
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Raises US$250,000 of Gross Proceeds in Convertible Note FinancingTORONTO and GLIL YAM, Israel, Aug. 7, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$250,000 convertible note financing in a private placement with an institutional investor (the "Lender"). Pursuant to a note purchase agreement between the Company and Lender dated August 6, 2026 (the "August Note Purchase Agreement"), the Company issued the Lender a note in the principal amount of US$250,000, with an original issuance discount of 10% (the "August Note").The August Note bears interest at a rate of 8% per annum, increasing to 14% upon the occurrence and continua
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Provides Corporate UpdateTORONTO and GLIL YAM, Israel, July 27, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, announces that Mr. Alon Dayan has resigned as a director of the Company for personal reasons. The board of directors and management of IM Cannabis thank Mr. Dayan for his service and valuable contributions to the Company during his tenure and extend their best wishes to him in his future endeavours.About IM Cannabis Corp.IMC (NASDAQ:IMCC) is an international company focused on building and scaling innovative businesses and technologies across global markets. The Company currently operates a medical cannabis pla
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note FinancingTORONTO and GLIL YAM, Israel, July 1, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$225,000 convertible note financing in a private placement with an institutional investor (the "Lender"). Pursuant to a note purchase agreement between the Company and Lender dated July 1, 2026 (the "July Note Purchase Agreement"), the Company issued the Lender a note in the principal amount of US$225,000, with an original issuance discount of 10% (the "July Note").The July Note bears interest at a rate of 8% per annum, increasing to 14% upon the occurrence and continuation of
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Corp. Enters into Letter of Intent to Sell its European Activities, Expects to Significantly Reduce Debt by CAD$10.5 millionTransaction Expected to Streamline Operations, Retain Israeli Business, Improve Working Capital through debt reduction and Cash Flow While Enabling the Pursuit of New Investment Opportunities as Previously AnnouncedTORONTO and GLIL YAM, Israel, June 18, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, is pleased to announce that it has entered into a non-binding letter of intent (the "Letter of Intent") with Slil.com Holding Ltd., a privately-held Israeli entity beneficially owned and controlled by Oren Shuster, the Company's Chief Executive Officer, a director and debtholder of IMC ("Slil"), purs
- SECSEC Form EFFECT filed by IM Cannabis Corp.EFFECT - IM Cannabis Corp. (0001792030) (Filer)
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Announces Form F-3 Resale Registration Statement FilingTORONTO and GLIL YAM, Israel, June 9, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, announces that, further to its press releases dated May 7, 2026 and June 3, 2026, it has filed a resale registration statement on Form F-3 (the "Resale Registration Statement") with the Securities and Exchange Commission (the "SEC"). The Resale Registration Statement registered an aggregate of 17,276,931 common shares in the capital of the Company ("Common Shares") comprised of: (i) up to 4,000,000 Common Shares issued or issuable upon the conver
- SECSEC Form F-3 filed by IM Cannabis Corp.F-3 - IM Cannabis Corp. (0001792030) (Filer)
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note FinancingTORONTO and GLIL YAM, Israel, June 3, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$225,000 convertible note financing in a private placement with an institutional investor (the "Lender"). Pursuant to a note purchase agreement between the Company and Lender dated June 3, 2026 (the "June Note Purchase Agreement"), the Company issued the Lender a note in the principal amount of US$225,000, with an original issuance discount of 10% (the "June Note").The June Note bears interest at a rate of 8% per annum, increasing to 14% upon the occurrence and continuation of
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Corp. Announces First Quarter 2026 Financial ResultsTORONTO and GLIL YAM, Israel, May 13, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced its financial results for the first quarter ended March 31, 2026. All amounts were reported in Canadian dollars, unless otherwise stated. For the three months ended March 31, 2026, the Company recorded revenues of $8.7 million, gross profit of $1.4 million, operating loss of $1.7 million, and a net loss of $2.5 million, or $0.38 per share. The Company also continued to advance its co
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note FinancingsTORONTO and GLIL YAM, Israel, May 7, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$300,000 convertible note financing in a private placement with an institutional investor, bringing the total gross proceeds raised in recent similar financings to US$550,000. First NotePursuant to a note purchase agreement between the Company and Lender dated April 6, 2026 (the "First Note Purchase Agreement"), the Company issued the Lender a note in the principal amount of US$250,000, with an original issuance discount of 10% (the "First Note").The First Note bears interest at
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
IMCC FAQ
6 questionsWhat does IM Cannabis Corp. do?
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers strains under the Roma, Dairy Queen, London, Tel Aviv, Paris, and Pandora Box brands; and CBD oil products under the IMC brand. The company also offers its intellectual property related services to the medical cannabis industry. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.Where does IMCC stock trade?
IM Cannabis Corp. (IMCC) is listed on NASDAQ.What sector and industry is IMCC in?
IM Cannabis Corp. operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.What are analysts saying about IMCC?
IM Cannabis Corp. has had 3 recent analyst actions on file. The most recent action was from ROTH Capital: Buy with a $800.00 price target on 2021-10-05. Recent price targets range from $800.00 to $1050.00.What companies are similar to IMCC?
Notable peers in the same industry include PM (Philip Morris International Inc), BTI (British American Tobacco Industries p.l.c.), MO (Altria Group Inc.), DFTX (Definium Therapeutics Inc.), CGC (Canopy Growth Corporation). Compare IMCC side-by-side with any of them on Quantisnow.How can I track IMCC on Quantisnow?
Quantisnow aggregates IM Cannabis Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow IMCC to receive live email and push alerts on every new disclosure.